Migraine treatment and work absence trends before and after introduction of calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs): A nationwide Swedish register study.
Saved in:
| Title: | Migraine treatment and work absence trends before and after introduction of calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs): A nationwide Swedish register study. |
|---|---|
| Authors: | Liseth Hansen, Johan A.1,2 (AUTHOR) j.a.l.hansen@medisin.uio.no, Skira, Meghan3 (AUTHOR), Wangen, Knut Reidar1 (AUTHOR) |
| Source: | Cephalalgia Reports. 2/4/2026, Vol. 9, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 25158163 |
|---|---|
| DOI: | 10.1177/25158163261421617 |
